From the Editor-in-Chief

Researchers seek to understand why cancers stop responding to targeted treatments even after initially dramatic responses.

by William G. Nelson, MD, PhD, DSc

Forward Look

Medical oncologist Umang Swami notes the importance of educating patients about the value of tumor testing.

by Lindsey Leake

Forward Look

Targeted treatment that blocks glucocorticoid receptors appears to disrupt signaling that helps ovarian cancer cells withstand chemotherapy.

by Cameron Walker

Forward Look

A pilot program shows some people with cancer may safely receive chemotherapy at home.

by Laura Gesualdi Gilmore

Forward Look

Study shows that adding hormone therapy to postoperative radiation did not improve overall survival in men with low PSA levels.

by Ashley P. Taylor

Forward Look

For those using e-cigarettes to stop smoking, nicotine vaping comes with its own health risks.

by Brianna Abbott

As some antibody-drug conjugates move into first-line and early-stage treatment, researchers seek new targets, payloads and combinations to reach more types of cancer.

by Kendall K. Morgan

CAR T-cell therapies and bispecific antibodies offer options for people with relapsed or refractory multiple myeloma.

by Jo Cavallo

Q&A

Lung cancer survivor Shira Kupperman Boehler makes the case for earlier, more readily available screening.

by Darcy Lewis

Sound Advice

An oncology nurse offers advice for people about to begin chemotherapy, addressing how long visits will take and what to bring with them.